27 Jul World Hepatitis Day: The Silent Disease Most People Do Not Know They Have
Viral hepatitis affects an estimated 354 million people worldwide. Most do not know they are infected. That number is worth sitting with. It is larger than the population of the United States. And for the overwhelming majority of those people, the disease is working quietly, without a single symptom to give it away.
This is what makes hepatitis different from most illnesses people worry about. There is no fever that sends someone to urgent care. No pain that forces a doctor’s visit. Hepatitis B and C can live in the body for years, sometimes decades, without announcing themselves at all.
The Disease That Hides in Plain Sight
Hepatitis B and C attack the liver. Slowly. Steadily. Without symptoms to mark their progress. A person can feel completely healthy while the virus quietly causes inflammation and scarring over time. Left untreated, that damage can progress to cirrhosis. In some cases, it leads to liver cancer.
By the time symptoms appear, if they appear at all, significant damage may have already been done. That is the danger of a silent disease. It does not ask for attention. It has to be looked for.
A Burden That Is Not Evenly Shared
Hepatitis does not affect every community equally. In the United States, Asian American and Pacific Islander adults have the highest rates of chronic hepatitis B of any population. Much of this traces back to transmission patterns in regions with limited vaccination coverage, often passed from mother to child before broader vaccination programs were in place.
People who have experienced incarceration also face disproportionately high rates of hepatitis infection, shaped by limited access to healthcare and screening both inside and outside the system.
These are not abstract statistics. They represent real gaps in who gets tested, who gets treated, and who gets left behind. Community-based screening programs have shown real promise here. When testing is brought directly into these communities, detection rates rise. People who would have otherwise gone undiagnosed get the chance to act early.
Testing Is Simple. Treatment Exists.
Here is the part that deserves more attention than it gets: hepatitis is manageable. Testing for hepatitis B and C is a simple blood panel. It does not require a specialist referral or an invasive procedure. A single test can offer answers that shape the rest of a person’s health.
And treatment works. Hepatitis C can often be cured with modern antiviral medications. Hepatitis B can be managed effectively with long-term care, protecting the liver from further damage. Neither of these outcomes requires guesswork. They require a diagnosis.
That is why hepatitis testing is recommended for all adults, at least once, as part of routine preventive care. Not just those in high-risk groups. Not just those with symptoms. Everyone. A single hepatitis B and C panel, discussed with a provider, can close the distance between not knowing and knowing.
The Gap Is Not Knowledge. It Is Access.
The tools to catch and treat hepatitis already exist. What is missing is not medical understanding. It is the routine integration of testing into everyday preventive care. It is awareness that this disease is common, not rare. It is access to screening in the communities that need it most.
Closing that gap requires more than individual action. It requires systems built around routine screening. It requires healthcare providers who ask the question before a patient has to. It requires community programs that meet people where they are, rather than waiting for them to come forward.
A Call for World Hepatitis Day
On World Hepatitis Day, the message is simple. Hepatitis does not have to remain silent. Testing is available. Treatment works. What stands between millions of people and a diagnosis is not complexity. It is whether screening becomes routine, and whether care becomes reachable.
At Muse Health, we support systems that make preventive screening easier to access and act on. We believe no one should carry a silent disease unknowingly, simply because testing was not offered or access was out of reach.
Ask a provider about a hepatitis B and C panel. It takes one conversation to start closing the gap.